Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Phase 2 orforglipron data demonstrated 14.7% body weight reduction at 45mg without food or water requirements, and the addressable patient expansion is estimated to grow the anti-obesity medication market by 180 million new prescription patients between 2027 and 2032
US-licensed providers evaluate every prescription individually Studied by our Stanford PhD-led Research Team in the $101M XPRIZE Healthspan competition Rigorously tested for purity and potency by LegitScript-certified pharmacy partners Read our Research AgelessRx researchers are one of 40 global teams competing in the $101M XPRIZE Healthspan competition, studying Glutathione with other therapies to measure real-world impacts reversing brain, muscle, and immune system aging
Neither medication should be used in individuals with a personal or family history of these conditions
Understanding Semaglutide 2
US$ 29.04
US$ 25.23
US$ 23.38
US$ 20.84
